A non-invasive breast cancer detection test

Developing a patient-friendly screening method to detect breast cancer from sweat collected from a fingertip

The clinical need:

Breast cancer is the most frequently diagnosed cancer among women globally and a leading cause of cancer-related mortality. The earlier the breast cancer is diagnosed, the higher the chance of survival. Currently, the main screening method is mammography, based on an X-ray scan, an often painful procedure, which has to be conducted by a health professional.

Project challenge:

A team led by Professor Simona Francese from Sheffield Hallam University has developed a non-invasive and patient-friendly breast screening test that could be deployed in at-home settings. As the development is at the proof-of-concept stage, the team was eager to understand the market opportunity for this new screening method, which would help define a commercial engagement strategy.

How did Medipex help?

Medipex has conducted research to deepen the understanding of the clinical need, market size, and the relevant NHS clinical pathways. This knowledge helped with the search strategy to identify the most relevant competitors and patents.

The project was funded by PBIAA (Place-Based Impact Acceleration Account) POM (Proof of Market).  

Impact:

The findings highlighted market opportunities, potential barriers to market entry, and suggested the next steps towards engagement with the stakeholders and IP protection.

The information from the report immediately supported development of a full stage MRC IAA application.

Client testimonial:

‘The report is incredibly valuable.’ Professor Simona Francese

 

Image designed by Freepik